What's New
New Prescriber Update edition published
We've published the latest edition of Prescriber Update.
This edition includes medicine safety information for non-steroidal anti-inflammatory drugs (NSAIDs), opioids and serotonergic medicines, prostaglandins, and more.
News and Events
| Date | Type | Title |
|---|---|---|
| 14/9/2022 | COVID-19 | Adverse events following immunisation with COVID-19 vaccines: Safety Report #45 – 31 August 2022 |
| 8/9/2022 | Alert Communication | Myocarditis and pericarditis have been reported with Nuvaxovid (Novavax COVID-19 Vaccine) |
| 5/9/2022 | Alert Communication | Recall of KetoSens Test Strips - batch UJ03PBXNG |
| 1/9/2022 | Publications | Prescriber Update Vol. 43 No. 3 – September 2022 |
| 29/8/2022 | Monitoring Communication |  Update – Possible risk of vasculitis with vildagliptin products (Galvus, Galvumet) |
| 25/8/2022 | Monitoring Communication | Abnormal uterine bleeding and oral anticoagulants (blood thinners) |
| 22/8/2022 | Committees | Agenda for the 69th Medicine Classification Committee Meeting - Comments due by 3 October 2022 |
| 17/8/2022 | Medicines | Updated Changed Medicine Notification Form A (effective from August 2022) |
| 5/8/2022 | Committees | Minutes of the 190th Medicines Adverse Reactions Committee Meeting |
